Benzinga | May 17, 2021 08:11AM EDT

F-star Therapeutics Q1 EPS $(1.08) Beats $(1.16) Estimate, Sales $2.92M Beat $1.20M Estimate

F-star Therapeutics (NASDAQ:FSTX) reported quarterly losses of $(1.08) per share which beat the analyst consensus estimate of $(1.16) by 6.9 percent. The company reported quarterly sales of $2.92 million which beat the analyst consensus estimate of $1.20 million by 143.08 percent.